92 studies found for:    Open Studies | "Endometrial Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Conditions: Endometrial Adenoacanthoma;   Endometrial Adenocarcinoma;   Endometrial Adenosquamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma
Interventions: Radiation: brachytherapy;   Radiation: 3-dimensional conformal radiation therapy;   Drug: cisplatin
22 Recruiting Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer
Condition: Endometrial Cancer
Intervention:
23 Recruiting Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
Conditions: Ovarian Cancer;   Endometrial Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Selinexor
24 Recruiting Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Conditions: Cervical Cancer;   Uterine Endometrial Cancer;   Ovarian Cancer
Interventions: Procedure: Laparotomy;   Drug: intravenous narcotics;   Drug: standard anesthesia;   Drug: regional anesthesia;   Drug: Non-steroidal  anti-inflammatory drugs
25 Recruiting Thunderbeat Technology vs Standard Bipolar Electro-surgery in Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: Thunderbeat technology;   Procedure: Standard bipolar electrosurgery
26 Recruiting Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
Conditions: Complex Atypical Hyperplasia;   Endometrial Cancer
Intervention: Drug: Metformin
27 Recruiting Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma;   Stage IIIA Endometrial Carcinoma;   Stage IIIB Endometrial Carcinoma;   Stage IIIC Endometrial Carcinoma;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Drug: metformin hydrochloride;   Other: placebo;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment;   Other: questionnaire administration
28 Recruiting Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Endometrial Adenosquamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma;   Stage IIIA Endometrial Carcinoma;   Stage IIIB Endometrial Carcinoma;   Stage IIIC Endometrial Carcinoma;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Drug: dasatinib;   Drug: paclitaxel;   Drug: carboplatin;   Other: laboratory biomarker analysis
29 Unknown  Screening of Biomarkers on Endometrial Cancers
Condition: Endometrial Cancers
Intervention: Procedure: surgery
30 Recruiting Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors
Conditions: Endometrial Cancer;   Obesity
Interventions: Dietary Supplement: Dietary Intervention;   Other: Informational Material;   Other: Dietary Education;   Dietary Supplement: Weight Maintenance;   Other: Average score of Obesity and Weight-Loss Quality of Life Questionnaire
31 Recruiting Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Device: MIrena(LNG-IUS), oral MPA
32 Recruiting Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Conditions: Endometrial Adenosquamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Drug: cabozantinib-s-malate;   Other: laboratory biomarker analysis;   Other: pharmacological study
33 Recruiting Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Radiation: 3D conformational radiation;   Radiation: IMRT
34 Unknown  Radiation Therapy Sandwiched Between Paclitaxel and Carboplatin in Patients With High-risk Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Pelvic and Para-Aortic Radiation 6MV Photon Beam Energy;   Radiation: High Dose Radiation
35 Unknown  Prognostic Biomarkers in Patients With Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Genetic: DNA analysis;   Genetic: mutation analysis;   Other: laboratory biomarker analysis
36 Unknown  Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: lymphadenectomy;   Procedure: therapeutic conventional therapy;   Procedure: Positron Emission Tomography/ Computed Tomography;   Radiation: fludeoxyglucose F 18
37 Unknown  Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: single-port laparoscopic surgical staging;   Procedure: Four-port laparoscopic surgical staging
38 Recruiting Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
Conditions: Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer;   Stage IIIA Endometrial Carcinoma;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Endometrial Carcinoma;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Endometrial Carcinoma;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Procedure: therapeutic conventional surgery;   Drug: cisplatin;   Drug: carboplatin;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
39 Recruiting Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
Condition: Endometrial Cancer
Interventions: Device: ISB dye and standard white light imaging;   Device: ICG dye and FireFly fluorescence imaging
40 Unknown  A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients
Condition: Endometrial Cancer
Intervention: Drug: paclitaxel

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years